A Woman’s Heart: Why Cardiovascular Prevention Matters More in Midlife
Understand how hormones, metabolism, and emerging cardiovascular research can help us protect heart health long before symptoms appear.
Heart disease remains the leading cause of death among women in the United States, yet cardiovascular health is often overlooked during the very years when important changes in risk begin to occur.
For many women, their forties and fifties bring noticeable changes in sleep, energy, body composition, and hormone balance. We frequently associate these changes with perimenopause and menopause, and understandably so. However, what many women don’t realize is that this hormonal transition is also a particularly important time to evaluate cardiovascular health.
At our practice, we believe that the best approach to heart disease is to identify and address risk factors long before symptoms develop. And increasingly, cardiovascular research is helping us understand why a more comprehensive, individualized approach is especially important for women.
Menopause and Your Heart: An Important Connection
Estrogen plays a role in maintaining vascular health, influencing cholesterol metabolism, and supporting the normal function of blood vessels. As estrogen levels decline during menopause, changes can occur that influence a woman’s long-term cardiovascular risk.
One of the most important studies examining this relationship is the Study of Women’s Health Across the Nation (SWAN), a large longitudinal study that followed more than 3,000 women through the menopausal transition.
Researchers found that total cholesterol, LDL cholesterol, and apolipoprotein B (ApoB) increased more rapidly around the time of the final menstrual period, even after accounting for chronological aging.
These findings help us understand that some cardiovascular changes are not simply a consequence of getting older. The menopausal transition itself appears to contribute to changes in lipid metabolism that can influence future cardiovascular risk.
This is particularly important because these changes can occur without any noticeable symptoms.
A woman may feel perfectly healthy while cardiovascular risk factors are gradually increasing.
Clinical research: Matthews KA et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? Journal of the American College of Cardiology, 2009.
Why a Standard Cholesterol Panel May Not Tell the Whole Story
Most women are familiar with having their cholesterol checked during an annual physical. Traditionally, we have focused on total cholesterol, LDL cholesterol, HDL cholesterol, and triglycerides.
While these measurements remain important, newer research has helped us better understand that cholesterol levels alone may not always fully reflect cardiovascular risk.
One particularly valuable marker is apolipoprotein B, or ApoB.
ApoB provides an estimate of the number of potentially plaque-forming lipoprotein particles circulating in the bloodstream. This is different from LDL cholesterol, which measures the amount of cholesterol carried within LDL particles.
Why does this distinction matter? Two women can have similar LDL cholesterol levels but very different numbers of circulating atherogenic particles. The woman with the greater particle burden may have a higher risk of developing atherosclerotic cardiovascular disease.
In a study involving more than 27,000 women from the Women’s Health Study, researchers demonstrated that when LDL cholesterol and ApoB levels were discordant, LDL cholesterol alone could either underestimate or overestimate future coronary risk.
This does not mean that every woman needs extensive advanced lipid testing. However, ApoB can provide valuable additional information, particularly in women with insulin resistance, diabetes, elevated triglycerides, or other metabolic risk factors.
Clinical research: Mora S et al. Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events. Circulation, 2014.
Lipoprotein(a): An Important Inherited Risk Factor
Another cardiovascular marker receiving increased attention is lipoprotein(a), commonly abbreviated Lp(a).
Unlike many cardiovascular risk factors, Lp(a) is largely genetically determined and generally changes very little in response to diet and exercise.
This means that a woman can maintain a healthy weight, exercise consistently, eat a nutritious diet, and still have an inherited elevation in Lp(a) that increases her cardiovascular risk.
Elevated Lp(a) is associated with an increased risk of atherosclerotic cardiovascular disease and calcific aortic valve disease.
Because Lp(a) is primarily inherited, measuring it at least once during adulthood can provide important information about an individual’s lifelong cardiovascular risk.
When Lp(a) is elevated, our focus becomes even more intentional management of other modifiable risk factors, including LDL cholesterol, blood pressure, blood sugar, smoking, and overall metabolic health.
Importantly, identifying elevated Lp(a) may also provide useful information for family members who share the same genetic risk.
Scientific evidence: Kronenberg F et al. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. European Heart Journal, 2022.
Your Pregnancy History May Reveal Important Clues About Your Heart
One of the most interesting developments in women’s cardiovascular medicine is the increasing recognition that reproductive history provides important information about future cardiovascular health.
Complications such as preeclampsia, gestational hypertension, gestational diabetes, and preterm delivery are associated with increased cardiovascular risk later in life.
For example, a systematic review and meta-analysis published in the BMJ found that women with a history of preeclampsia had approximately twice the risk of subsequent ischemic heart disease compared with women who had not experienced preeclampsia.
This does not mean that women with pregnancy complications will necessarily develop cardiovascular disease. Rather, these experiences may identify women who would benefit from earlier and more intentional cardiovascular screening and prevention.
Premature menopause, particularly before age 40, is another important risk-enhancing factor.
Your reproductive history is part of your cardiovascular history, and it deserves to be included in your long-term preventive care.
Clinical research: Bellamy L et al. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ, 2007.
Recognizing Heart Disease in Women: Symptoms Aren’t Always What We Expect
Although our goal is to prevent cardiovascular disease before symptoms develop, recognizing the warning signs of a heart attack remains critically important.
Chest discomfort, including pressure, tightness, or pain, is the most common heart attack symptom in both women and men.
However, women may also experience additional symptoms such as shortness of breath, nausea, unusual fatigue, sweating, or discomfort involving the jaw, neck, back, shoulders, or arms.
These symptoms can sometimes be mistaken for anxiety, gastrointestinal discomfort, muscle strain, or hormonal changes.
Research from the VIRGO study, which evaluated younger women and men hospitalized with heart attacks, found that women were more likely to experience additional symptoms and were more likely to attribute their symptoms to stress or anxiety.
The important message is that we should never automatically assume that new or unusual symptoms are simply related to menopause or stress.
Clinical research: Lichtman JH et al. Sex Differences in the Presentation and Perception of Symptoms Among Young Patients With Myocardial Infarction. Circulation, 2018.
If you develop new, severe, persistent, or concerning symptoms that could represent a heart attack, call 911 immediately rather than attempting to evaluate or manage them yourself.
What Does a Comprehensive Cardiovascular Evaluation Look Like?
Cardiovascular prevention should involve more than simply reviewing a cholesterol result and being told that everything looks normal.
A thoughtful, individualized evaluation may include:
- Traditional cardiovascular markers: Blood pressure, LDL cholesterol, HDL cholesterol, and triglycerides.
- Advanced lipid assessment: ApoB and Lp(a), when appropriate, to better understand atherogenic particle burden and inherited risk.
- Metabolic health: Fasting glucose, hemoglobin A1c, and evaluation of insulin resistance when clinically indicated.
- Inflammatory risk: High-sensitivity C-reactive protein (hs-CRP) in selected patients when it may help refine cardiovascular risk assessment.
- Hormonal and reproductive history: Menopausal status, premature menopause, and prior pregnancy complications.
- Family history: Particularly premature cardiovascular disease in parents or siblings.
Cardiovascular imaging: Coronary artery calcium scoring in selected patients when the results may help guide preventive treatment decisions. Emerging AI-enhanced coronary CT imaging technologies can also help differentiate between calcified, noncalcified, and potentially higher-risk plaque, providing a more comprehensive assessment of coronary artery disease.
Not every woman needs every test. The goal is to understand the individual factors that may contribute to her cardiovascular risk and determine which evaluations will meaningfully influence her care.
The Most Important Message: Heart Disease Prevention Begins Before Symptoms
What continues to excite me about preventive and longevity medicine is our growing ability to recognize patterns of risk long before disease becomes clinically apparent.
We know that cardiovascular health is influenced by much more than cholesterol alone. Hormonal changes, metabolic health, blood pressure, genetics, lifestyle, and reproductive history all contribute to the larger picture.
And while we cannot change every risk factor, there is so much we can do to influence cardiovascular health through appropriate screening, nutrition, exercise, sleep, blood pressure management, and evidence-based medical treatment when needed. For women entering perimenopause or menopause, this is an especially valuable time to take a closer look at cardiovascular health.
The goal is not simply to identify heart disease earlier. It is to recognize risk sooner, address the factors we can change, and help preserve cardiovascular health for decades to come.
At Ruthie Harper MD, our approach to preventive and longevity medicine is built around this philosophy: understanding the whole person, looking beyond isolated laboratory values, and using individualized assessments to support long-term health. Because protecting your heart is not just about preventing a heart attack. It’s about protecting your energy, independence, vitality, and quality of life as you age.
If you live in the greater Austin, TX area, schedule a consultation and Dr. Ruthie will be happy to help you explore your options.





